BW
NWBO

Biegel & Waller’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Biegel & Waller’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,500
Closed -$5K – 59
2016
Q4 		$5K Buy
+11,500
New +$5.79K ﹤0.01% 55

Other funds holding NWBO

MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
WPP
Whalerock Point Partners Providence, Rhode Island $587M AUM 29.61% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Biegel & Waller's NWBO Position: Q1 2017 in Review

Biegel & Waller sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2017, closing a stake of 11,500 shares — an estimated $5K sold.

Biegel & Waller first reported a position in NWBO in Q4 2016 and held it in 1 quarter. The position peaked at $5K in Q4 2016. 4 funds tracked by Wall St. Rank hold NWBO as of Q1 2017.

  • Biegel & Waller reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2017 after selling out during the quarter.
  • Biegel & Waller sold 11,500 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2017, an estimated $5K.
  • Biegel & Waller first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2016 and held it in 1 quarter.
  • Biegel & Waller's Northwest Biotherapeutics, Inc. Common stock position peaked at $5K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2017.

Based on Biegel & Waller's 13F filing for Q1 2017, filed 12 May 2017.